LYMPHANGIOMA

Clinical trials for LYMPHANGIOMA explained in plain language.

Never miss a new study

Get alerted when new LYMPHANGIOMA trials appear

Sign up with your email to follow new studies for LYMPHANGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Promising drug targets rare, Life-Threatening vascular tumors

Disease control Not yet recruiting

This study tests the drug everolimus in 67 people with rare blood vessel growths (vascular anomalies) that haven't responded to other treatments. The goal is to see if the drug can shrink these growths and improve symptoms. Participants take everolimus daily for up to 3 years, wi…

Matched conditions: LYMPHANGIOMA

Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control

Last updated Jun 12, 2026 12:03 UTC

LYMPHANGIOMA

Get alerted when new LYMPHANGIOMA trials appear

Promising drug targets rare, Life-Threatening vascular tumors